Delivery Order SPE2DB24D1205-SPE2DB24FCUZK

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $51,389.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,567,028,300 units of Citalopram HBR 20 mg tablets. The contract is a firm fixed-price type with a final completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,370.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,057,445 units of the prescription drug Citalopram HBR 20 mg tablet, with a period of performance ending on January 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $9,959.10, is for the delivery of Citalopram HBR 20 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 9, 2023. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,473,890 units of Citalopram HBR 40 mg tablets. The fixed-price delivery order has a ceiling value of $28,331.92 and an ultimate completion date of October 16, 2023. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of 4,563,401,917 units of Citalopram HBR 20 mg tablets. The contract has a firm fixed price of $9,559.04 and a completion date of January 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,166.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,873,359 tablets of the medication Citalopram HBR 40 mg, with a completion date of April 11, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,680,284 units of Citalopram HBR 40 mg tablets. The $3,805.46 firm fixed-price Delivery Order has a completion date of February 16, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,958.23, is a delivery order for 4,562,704,033 units of Citalopram HBR 40 mg tablets. The contract has a firm fixed price and an ultimate completion date of November 6, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,474,076 units of the drug Citalopram HBR 40 mg tablets, with a ceiling value of $4,172.32. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 16, 2023. This award is a part of a larger Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,409.47, is for the delivery of Citalopram HBR 20 mg tablets in quantities of 500 per bottle. It is a firm fixed-price delivery order contract with an ultimate completion date of October 17, 2023. The contract award is not designated as a set-aside and appears to be part of a larger Indefinite...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCUZK
    Delivery Order

This federal contract award, valued at $5,175.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of 4,565,911 units of Citalopram HBR 20 mg tablets. The contract has a firm fixed price and an ultimate completion date of September 24, 2024. This award is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies. The contract does not have a set-aside designation.

Generated 12/23/24, 2:44 PM